Stocks and Investing Stocks and Investing
Thu, August 15, 2024

Gregory Renza Maintained (VRCA) at Buy with Decreased Target to $13 on, Aug 15th, 2024


Published on 2024-10-28 13:41:03 - WOPRAI, Gregory Renza
  Print publication without navigation


Gregory Renza of RBC Capital, Maintained "Verrica Pharmaceuticals Inc." (VRCA) at Buy with Decreased Target from $14 to $13 on, Aug 15th, 2024.

Gregory has made no other calls on VRCA in the last 4 months.



There is 1 other peer that has a rating on VRCA. Out of the 1 peers that are also analyzing VRCA, 0 agree with Gregory's Rating of Hold.



This is the rating of the analyst that currently disagrees with Gregory


  • Oren Livnat of "HC Wainwright & Co." Maintained at Strong Buy with Increased Target to $14 on, Tuesday, May 14th, 2024
Contributing Sources